Suppr超能文献

评价 2013-2020 年立陶宛根治方案的有效性:来自欧洲管理登记处(Hp-EuReg)的数据。

Evaluation of the Effectiveness of Eradication Regimens in Lithuania during the Years 2013-2020: Data from the European Registry on Management (Hp-EuReg).

机构信息

Department of Gastroenterology, Lithuanian University of Health Sciences, 50161 Kaunas, Lithuania.

Gastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Universidad Autónoma de Madrid (UAM), 28006 Madrid, Spain.

出版信息

Medicina (Kaunas). 2021 Jun 23;57(7):642. doi: 10.3390/medicina57070642.

Abstract

: The prevalence of in Eastern Europe remains quite high; however, there is insufficient data on the eradication regimens and their effectiveness. Therefore, the objective of the study was to evaluate the diagnostic methods and treatment of infection as well as their adherence to Maastricht V/Florence consensus during the years 2013-2020 in Lithuania. : Sub-study of the "European Registry on Management" (Hp-EuReg), international multicenter prospective non-interventional registry of the routine clinical practice. Lithuanian data from the years 2013-2020 were analyzed for effectiveness on a modified intention-to-treat (mITT) basis. 2000 adult patients, diagnosed with infection, were included. Data were compared to the European Maastricht V guidelines. : Triple-therapy was used in 90% of the cases. In 91% of the first-line prescriptions, standard triple therapy (STT) was used. The most common second-line treatment was a combination of PPI, amoxicillin and levofloxacin (PPI+A+L) (47%). The overall effectiveness in 552 cases valid for analysis was 90% by mITT. In first-line treatment, the STT effectiveness was 90% and second-line treatment with PPI+A+L achieved 92% by mITT. Increasing overall eradication rates were observed: from 72% in 2013 to more than 90% in 2018-2020, as well as a shift from 7 to 10-14 days treatments duration throughout 2013-2020. : In Lithuania, the prescribed eradication regimens for were in accordance with the international guidelines but diagnostic methods and treatment duration only partially met Maastricht V/Florence guidelines. The eradication effectiveness was improved progressively during the years 2018-2020, reaching ≥90% cure rates.

摘要

在东欧, 的流行率仍然相当高;然而,关于根除方案及其效果的数据不足。因此,本研究的目的是评估 2013-2020 年期间立陶宛 感染的诊断方法和治疗方法及其对马斯特里赫特 V/佛罗伦萨共识的遵循情况。这是“ 管理欧洲登记处”(Hp-EuReg)的子研究,这是一项国际多中心前瞻性非干预性常规临床实践登记处。分析了 2013-2020 年期间的立陶宛数据,基于改良意向治疗(mITT)进行了有效性评估。共纳入 2000 例成年 感染患者。将数据与欧洲马斯特里赫特 V 指南进行了比较。在 90%的病例中使用了三联疗法。在 91%的一线处方中,使用了标准三联疗法(STT)。最常见的二线治疗是质子泵抑制剂(PPI)、阿莫西林和左氧氟沙星的组合(PPI+A+L)(47%)。552 例可分析的总体有效性为 mITT 的 90%。在一线治疗中,STT 的有效性为 90%,PPI+A+L 的二线治疗的有效性为 mITT 的 92%。总体 根除率呈上升趋势:从 2013 年的 72%上升到 2018-2020 年的 90%以上,同时治疗持续时间从 7 天到 2013-2020 年的 10-14 天也有所改变。在立陶宛,规定的 根除方案符合国际指南,但诊断方法和治疗持续时间仅部分符合马斯特里赫特 V/佛罗伦萨指南。2018-2020 年期间,根除效果逐步提高,达到了≥90%的治愈率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f75/8305910/2c49185e67fa/medicina-57-00642-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验